Search research articles
Contact Us
Filters
Showing results (1-10 of 52) with videos related to
Page
of 6
Sort By:
Turkish Thoracic Journal
|
November 21, 2018
What Does the TOVITO Programme Tell Us about How We Can Manage COPD?
Richard E K Russell
Turkish Thoracic Journal
|
August 8, 2019
What will Happen in the World of COPD 2030?
Richard E K Russell, Mona Bafadhel
Turkish Thoracic Journal
|
September 4, 2019
The Use of Inhaled Corticosteroids to Prevent Acute Exacerbations of COPD: A Pro/Con Debate
Richard E K Russell, Ian Pavord
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
July 1, 1975
Biological properties of a type C virus isolated from a human X mouse hybrid cell line
A F Gazdar, E K Russell, J Minna
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 1974
Replication of mouse-tropic and xenotropic strains of murine leukemia virus in human x mouse hybrid cells
A F Gazdar, E K Russell, J D Minna
The Lancet. Respiratory Medicine
|
June 12, 2017
Eosinophils in COPD: just another biomarker?
Mona Bafadhel, Ian D Pavord, Richard E K Russell
BMC Pulmonary Medicine
|
September 24, 2021
Renaming COPD exacerbations: the UK respiratory nursing perspective
Christine Mwasuku, Joanne King, Richard E K Russell, et al.
Plos One
|
August 20, 2021
Predicting treatment outcomes following an exacerbation of airways disease
Andreas Halner, Sally Beer, Richard Pullinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1997
Paclitaxel cytotoxicity against human lung cancer cell lines increases with prolonged exposure durations
M S Georgiadis, E K Russell, A F Gazdar, et al.
Journal of Cellular Biochemistry. Supplement
|
January 1, 1996
Cell culture methods for the establishment of the NCI series of lung cancer cell lines
H K Oie, E K Russell, D N Carney, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 52) with videos related to
Sort By:
Page
of 6
Turkish Thoracic Journal
|
November 21, 2018
What Does the TOVITO Programme Tell Us about How We Can Manage COPD?
Richard E K Russell
Turkish Thoracic Journal
|
August 8, 2019
What will Happen in the World of COPD 2030?
Richard E K Russell, Mona Bafadhel
Turkish Thoracic Journal
|
September 4, 2019
The Use of Inhaled Corticosteroids to Prevent Acute Exacerbations of COPD: A Pro/Con Debate
Richard E K Russell, Ian Pavord
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
|
July 1, 1975
Biological properties of a type C virus isolated from a human X mouse hybrid cell line
A F Gazdar, E K Russell, J Minna
Proceedings of the National Academy of Sciences of the United States of America
|
July 1, 1974
Replication of mouse-tropic and xenotropic strains of murine leukemia virus in human x mouse hybrid cells
A F Gazdar, E K Russell, J D Minna
The Lancet. Respiratory Medicine
|
June 12, 2017
Eosinophils in COPD: just another biomarker?
Mona Bafadhel, Ian D Pavord, Richard E K Russell
BMC Pulmonary Medicine
|
September 24, 2021
Renaming COPD exacerbations: the UK respiratory nursing perspective
Christine Mwasuku, Joanne King, Richard E K Russell, et al.
Plos One
|
August 20, 2021
Predicting treatment outcomes following an exacerbation of airways disease
Andreas Halner, Sally Beer, Richard Pullinger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 1, 1997
Paclitaxel cytotoxicity against human lung cancer cell lines increases with prolonged exposure durations
M S Georgiadis, E K Russell, A F Gazdar, et al.
Journal of Cellular Biochemistry. Supplement
|
January 1, 1996
Cell culture methods for the establishment of the NCI series of lung cancer cell lines
H K Oie, E K Russell, D N Carney, et al.
Page
of 6